Cited by 1,287Neuroinflammation and Neurodegeneration MechanismsAlzheimer's disease research and treatmentsTryptophan and brain disorders

The DOI matches its Crossref record; 311 of the 319 references it cites were found in a registry or an index.

The inflammatory response system of brain: implications for therapy of Alzheimer and other neurodegenerative diseases

MCGEER, P, MCGEER, E·1995·Brain Research Reviews

DOI 10.1016/0165-0173(95)00011-9

Open this paper in CoChat — free account

Abstract

Cultured brain cells are capable of generating many molecules associated with inflammatory and immune functions. They constitute the endogenous immune response system of brain. They include complement proteins and their regulators, inflammatory cytokines, acute phase reactants and many proteases and protease inhibitors. Most of the proteins are made by microglia and astrocytes, but even neurons are producers. Many appear in association with Alzheimer disease lesions, indicating a state of chronic inflammation in Alzheimer disease brain. Such a state can apparently exist without stimulation by peripheral inflammatory mediators or the peripheral immune system. A strong inflammatory response may be autotoxic to neurons, exacerbating the fundamental pathology in Alzheimer disease and perhaps other neurological disorders. Autotoxic processes may contribute to cellular death in chronic inflammatory diseases affecting other parts of the body, suggesting the general therapeutic value of anti-inflammatory agents. With respect to Alzheimer disease, multiple epidemiological studies indicate that patients taking anti-inflammatory drugs or suffering from conditions in which such drugs are routinely used, have a decreased risk of developing Alzheimer disease. In one very preliminary clinical trial, the anti-inflammatory drug indomethacin arrested progress of the disease. New agents directed against the inflammatory processes revealed in studies of Alzheimer disease lesions may have broad therapeutic applications.

Integrity signals

Registry

Crossref · 10.1016/0165-0173(95)00011-9

Cites

311 of 311 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease.
Strittmatter, W. J., Saunders, A. M., Schmechel, D., Pericak-Vance, M., Enghild, J., Salvesen, G. S., & Roses, A. D. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.5.1977 · Cited by 4,268
Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease
Sherrington, R., Rogaev, E. I., Liang, Y., Rogaeva, E. A., Levesque, G., Ikeda, M., Chi, H., Lin, C., Li, G., Holman, K., et al. (1995) · Nature · doi:10.1038/375754a0 · Cited by 4,051
Preparation of separate astroglial and oligodendroglial cell cultures from rat cerebral tissue.
McCarthy, K. D., & de Vellis, J. (1980) · The Journal of Cell Biology · doi:10.1083/jcb.85.3.890 · Cited by 3,845
Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease
Arriagada, P. V., Growdon, J. H., Hedley-Whyte, E. T., & Hyman, B. T. (1992) · Neurology · doi:10.1212/wnl.42.3.631 · Cited by 2,668
Secretory products of macrophages.
Nathan, C. F. (1987) · Journal of Clinical Investigation · doi:10.1172/jci112815 · Cited by 2,615
Candidate gene for the chromosome 1 familial Alzheimer’s disease locus
Levy-Lahad, E., Wasco, W., Poorkaj, P., Romano, D. M., Oshima, J., Pettingell, W. H., Yu, C.-E., Jondro, P. D., Schmidt, S. D., Wang, K., et al. (1995) · Science · doi:10.1126/science.7638622 · Cited by 2,577
Amyloid deposition as the central event in the aetiology of Alzheimer’s disease
Hardy, J., & Allsop, D. (1991) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(91)90609-v · Cited by 2,538
Interleukin-8 as a macrophage-derived mediator of angiogenesis
Koch, A. E., Polverini, P. J., Kunkel, S. L., Harlow, L. A., DiPietro, L. A., Elner, V. M., Elner, S. G., & Strieter, R. M. (1992) · Science · doi:10.1126/science.1281554 · Cited by 2,135
Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease.
Griffin, W. S., Stanley, L. C., Ling, C., White, L., MacLeod, V, Perrot, L. J., White, C. L., & Araoz, C. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.19.7611 · Cited by 1,777
Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease.
Schmechel, D. E., Saunders, A. M., Strittmatter, W. J., Crain, B. J., Hulette, C. M., Joo, S. H., Pericak-Vance, M. A., Goldgaber, D., & Roses, A. D. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.20.9649 · Cited by 1,525

Show all 319 references

Research works printed but not linked: 4

Del Rio Hortega, 1919, El ‘tercer elemento’ de los centros nerviosos. Poder fagocitario y movilidad de la microglia, Bol. Soc. Esp. Biol. Ano., ix, 154
Raine, 1990, Homing to central nervous system vasculature by antigen-specific lymphocytes, Lab. Invest., 63, 476
Shen, 1995, Expression of membrane attack complex contributes to the increased β-amyloid protein induced neuronal cell death by interruption of complement inhibitor CD59, Neurosci. Abstr., 21, 1009
Wisneiwski, 1973, Re-examination of the pathogenesis of the senile plaque, Vol. 2, 2

Sorted by citations

Items 301–400 of 1,000

Association of C‐reactive protein with mild cognitive impairment
Roberts, R. O., Geda, Y. E., Knopman, D. S., Boeve, B. F., Christianson, T. J. H., Pankratz, V. S., Kullo, I. J., Tangalos, E. G., Ivnik, R. J., & Petersen, R. C. (2009) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2009.01.025 · Cited by 136
“Inflammatory markers have been demonstrated in the AD brain [1,2,6,7].”
Background
Regulation of prostanoid synthesis in microglial cells and effects of prostaglandin E2 on microglial functions
Levi, G., Minghetti, L., & Aloisi, F. (1998) · Biochimie · doi:10.1016/s0300-9084(00)88886-0 · Cited by 133
Microglia and Alzheimer’s disease
Kalaria, R. N. (1999) · Current Opinion in Hematology · doi:10.1097/00062752-199901000-00004 · Cited by 135
Dietary fatty acids intake: possible role in cognitive decline and dementia
Solfrizzi, V., D’Introno, A., Colacicco, A. M., Capurso, C. A., DelParigi, A., Capurso, S. A., Gadaleta, A., Capurso, A., & Panza, F. (2005) · Experimental Gerontology · doi:10.1016/j.exger.2005.01.001 · Cited by 136
Microglia as a Pharmacological Target in Infectious and Inflammatory Diseases of the Brain
Rock, R. B., & Peterson, P. K. (2006) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-006-9012-8 · Cited by 130
“Following early epidemiological evidence that chronic use of nonsteroidal anti-inflammatory drugs (NSAIDS) was associated with a decreased risk of developing AD (McGeer and McGeer, 1995), the use of anti-inflammatory agents in the treatment of AD has been intensely studied.”
Background
Non-steroidal anti-inflammatory drugs have anti-amyloidogenic effects for Alzheimer's β-amyloid fibrils in vitro
Hirohata, M., Ono, K., Naiki, H., & Yamada, M. (2005) · Neuropharmacology · doi:10.1016/j.neuropharm.2005.07.004 · Cited by 132
“14 COX-1 and COX-2, leading to the suppression of prostaglandin synthesis and chronic neuroinflammation contributing to the protracted degenerative course of AD (McGeer and McGeer, 1995; Akiyama et al., 2000).”
Influential
Interleukin-8 receptor B immunoreactivity in brain and neuritic plaques of Alzheimer's disease.
Xia, M., Qin, S., McNamara, M. J., Mackay, C. R., & Hyman, B. T. (1997) · Europe PMC (PubMed Central) · Cited by 131
Nitric oxide pathways in Alzheimer's disease and other neurodegenerative dementias
Togo, T., Katsuse, O., & Iseki, E. (2004) · Neurological Research · doi:10.1179/016164104225016236 · Cited by 131
Vascular risk factors and Alzheimer’s disease
Cechetto, D. F., Hachinski, V., & Whitehead, S. N. (2008) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.8.5.743 · Cited by 133
Blood–brain barrier disruption induces in vivo degeneration of nigral dopaminergic neurons
Rite, I., Machado, A., Cano, J., & Venero, J. L. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04567.x · Cited by 147
“Activated microglia and mediators (cytokines, complement factors and acute phase reactants) are indeed commonly found to be closely associated to degenerating neurons (McGeer and McGeer 1995).”
Background
Infection, immunity and the neuroendocrine response
Borghetti, P., Saleri, R., Mocchegiani, E., Corradi, A., & Martelli, P. R. (2009) · Veterinary Immunology and Immunopathology · doi:10.1016/j.vetimm.2009.01.013 · Cited by 129
“IL-1, IL-6, Transforming Growth Factor (TGF)-b, LIF (Leukaemia Inhibitor Factor), MIF (Macrophage Inhibitor Factor), IL-10, IL-18 can be produced by the hypothalamus and/or pituitary glands (Breder et al., 1988 (Breder et al., , 1993 McGeer and McGeer, 1995; Maier and Watkins, 1998; Kronfol and Remick, 2000; Petrovsky…”
Background
New insights into COX-2 biology and inhibition
Patrignani, P., Tacconelli, S., Sciulli, M. G., & Capone, M. L. (2005) · Brain Research Reviews · doi:10.1016/j.brainresrev.2004.12.024 · Cited by 131
Properties of the pore‐forming P2X7 purinoceptor in mouse NTW8 microglial cells
Chessell, I. P., Michel, A. D., & Humphrey, P. P. A. (1997) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0701278 · Cited by 126
“…release various cytokines, nitric oxide and reactive oxygen species, particularly when activated in a manner analogous to macrophage activation (see McGeer & McGeer, 1995) and, as such, are thought to play a role in various neurodegenerative diseases, including multiple sclerosis (Hofman et al.,…”
Background
Brain Renin–Angiotensin System at the Intersect of Physical and Cognitive Frailty
Cosarderelioglu, C., Nidadavolu, L. S., George, C. J., Oh, E. S., Bennett, D. A., Walston, J. D., & Abadir, P. M. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.586314 · Cited by 134
“These products lead to an inflammatory response, microglial activation, and cytokine release, which then accelerates neuronal dysfunction and cognitive decline (Mcgeer and Mcgeer, 1995).”
Background
Blood-brain barrier integrity in the pathogenesis of Alzheimer’s disease
Huang, Z., Wong, L., Su, Y., Huang, X., Wang, N., Chen, H., & Yi, C. (2020) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2020.100857 · Cited by 135
Aspirin and non-steroidal anti-inflammatory drugs inhibit amyloid-β aggregation
Thomas, T., Nadackal, T. G., & Thomas, K. (2001) · Neuroreport · doi:10.1097/00001756-200110290-00024 · Cited by 128
C-reactive protein-like immunoreactivity in the neurofibrillary tangles of Alzheimer's disease
Duong, T., Nikolaeva, M. A., & Acton, P. J. (1997) · Brain Research · doi:10.1016/s0006-8993(96)01359-5 · Cited by 127
Inflammation as a potential mediator for the association between periodontal disease and Alzheimer’s disease
Watts, A. S., Gatz, M., & Crimmins, E. M. (2008) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s3610 · Cited by 129
Neural activities of IL‐6‐type cytokines often depend on soluble cytokine receptors
März, P., Otten, U., & Rose-John, S. (1999) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.1999.00755.x · Cited by 142
“In recent years experimental data have accumulated indicating that a chronic in¯ammatory process is part of the pathology of Alzheimer's disease (AD) (McGeer & McGeer, 1995).”
Background
Small heat shock protein HspB8: its distribution in Alzheimer’s disease brains and its inhibition of amyloid-β protein aggregation and cerebrovascular amyloid-β toxicity
Wilhelmus, M. M. M., Boelens, W. C., Otte‐Höller, I., Kamps, B., Küsters, B., Maat–Schieman, M. L. C., de Waal, R. M. W., & Verbeek, M. M. (2006) · Acta Neuropathologica · doi:10.1007/s00401-005-0030-z · Cited by 129
“The best studied proteins are heparan sulfate proteoglycans [40, 39], serum amyloid P [29], apolipoprotein E [42], a1-antichymotrypsin [1] and complement factors (C1q, C3d and C4d) [26].”
c-Abl in Neurodegenerative Disease
Schlatterer, S. D., Acker, C. M., & Davies, P. (2011) · Journal of Molecular Neuroscience · doi:10.1007/s12031-011-9588-1 · Cited by 127
“…Is Activated by and Contributes to Neuroinflammation Chronic neuroinflammation has been shown to occur in Alzheimer’s disease (reviewed in: (McGeer and McGeer 1995; Akiyama et al. 2000; Bamberger and Landreth 2002; Wyss-Coray and Mucke 2002; Wyss-Coray 2006; Glass et al. 2010)) and in…”
Neuroinflammatory Signals in Alzheimer Disease and APP/PS1 Transgenic Mice
López‐González, I., Schlüter, A., Aso, E., Garcia‐Esparcia, P., Ansoleaga, B., Llorens, F., Carmona, M., Moreno, J. R., Fuso, A., Portero‐Otín, M., et al. (2015) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0000000000000176 · Cited by 128
“The CNS is not an exception to this process, as innate immune cells in the brain 2015 American Association of Neuropathologists, Inc.336 Copyright © 2015 by the American Association of Neuropathologists, Inc. Unauthorized reproduction of this article is prohibited. become more reactive with aging (67).”
Background
Calcium dysregulation and neuroinflammation: Discrete and integrated mechanisms for age-related synaptic dysfunction
Sama, D. M., & Norris, C. M. (2013) · Ageing Research Reviews · doi:10.1016/j.arr.2013.05.008 · Cited by 129
Neuroinflammatory Cytokines Induce Amyloid Beta Neurotoxicity through Modulating Amyloid Precursor Protein Levels/Metabolism
Alasmari, F., Alshammari, M. A., Alasmari, A. F., Alanazi, W. A., & Alhazzani, K. (2018) · BioMed Research International · doi:10.1155/2018/3087475 · Cited by 125
Regulation of microglial inflammatory response by histone deacetylase inhibitors
Suuronen, T., Huuskonen, J., Pihlaja, R., Kyrylenko, S., & Salminen, A. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.02004.x · Cited by 123
“Inflammation and innate immune reactions are involved in the pathology of several neurodegenerative diseases and traumatic brain injuries (McGeer and McGeer 1995; Morg- anti-Kossmann et al. 2002; Wyss-Coray and Mucke 2002).”
Background
Glutamate and the glutamate receptor system: a target for drug action
Bleich, S., R�mer, K., Wiltfang, J., & Kornhuber, J. (2003) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.933 · Cited by 125
“This observation is important taking into account that it has been suggested that inflammation might play a major role in Copyright # 2003 John Wiley & Sons, Ltd. Int J Geriatr Psychiatry 2003; 18: S33–S40. neurodegeneration in Alzheimer‘s disease (McGeer and McGeer, 1995).”
Transient receptor potential channels in Alzheimer's disease
Yamamoto, S., Wajima, T., Hara, Y., Nishida, M., & Mori, Y. (2007) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2007.03.006 · Cited by 127
“In AD, microglia appear to cluster around Aβ plaques [105-107].”
Background
NSAIDs as potential treatment option for preventing amyloid β toxicity in Alzheimer’s disease: an investigation by docking, molecular dynamics, and DFT studies
Azam, F., Alabdullah, N. H., Ehmedat, H. M., Abulifa, A. R., Taban, I. M., & Upadhyayula, S. (2017) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2017.1338164 · Cited by 122
“Fibrillar β-amyloid deposits co-localize with numerous chronic inflammatory mediators and can activate the microglia in the brain (McGeer & McGeer, 1995).”
Background
Interleukin-1β activates forebrain glial cells and increases nitric oxide production and cortical glutamate and GABA release in vivo: implications for Alzheimer's disease
Casamenti, F., Prosperi, C., Scali, C., Giovannelli, L., Colivicchi, M. A., Faussone‐Pellegrini, M. S., & Pepeu, G. (1999) · Neuroscience · doi:10.1016/s0306-4522(98)00680-0 · Cited by 122
Circulating Biomarkers of Cognitive Decline and Dementia
Solfrizzi, V., D'Introno, A., Colacicco, A. M., Capurso, C., Todarello, O., Pellicani, V., Capurso, S. A., Pietrarossa, G., Santamato, V., Capurso, A., et al. (2006) · Clinica Chimica Acta · doi:10.1016/j.cca.2005.06.015 · Cited by 120
Heat Shock Proteins and Amateur Chaperones in Amyloid-Beta Accumulation and Clearance in Alzheimer’s Disease
Wilhelmus, M. M. M., de Waal, R. M. W., & Verbeek, M. M. (2007) · Molecular Neurobiology · doi:10.1007/s12035-007-0029-7 · Cited by 125
“fragments via phagocytosis [185–187].”
Cellular and Molecular Mechanisms of Parkinson’s Disease: Neurotoxins, Causative Genes, and Inflammatory Cytokines
Nagatsu, T., & Sawada, M. (2006) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-006-9061-9 · Cited by 122
“…along with the appearance of activated microglia, in the brain of sPD patients, thus suggesting the presence of an inflammatory process (McGeer and McGeer, 1995; Anglade et al., 1997; Hirsch et al., 1999; Mogi and Nagatsu, 1999; Nagatsu et al., 1999; Jellinger, 2000; Hartmann et al.,…”
Background
Minocycline prevents cholinergic loss in a mouse model of Down's syndrome
Hunter, C. L., Bachman, D., & Granholm, A. (2004) · Annals of Neurology · doi:10.1002/ana.20250 · Cited by 123
Dietary fatty acids in dementia and predementia syndromes: Epidemiological evidence and possible underlying mechanisms
Solfrizzi, V., Frisardi, V., Capurso, C. A., D’Introno, A., Colacicco, A. M., Vendemiale, G., Capurso, A., & Panza, F. (2009) · Ageing Research Reviews · doi:10.1016/j.arr.2009.07.005 · Cited by 123
Expression of cytokine genes and increased nuclear factor-kappa B activity in the brains of scrapie-infected mice
Kim, J., Ju, W., Choi, J., Kim, J., Choi, E., Carp, R. I., Wı́sniewski, H. M., & Kim, Y. (1999) · Molecular Brain Research · doi:10.1016/s0169-328x(99)00229-6 · Cited by 120
β-Amyloid Stimulates Murine Postnatal and Adult Microglia Cultures in a Unique Manner
Floden, A. M., & Combs, C. K. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.4822-05.2006 · Cited by 118
“Fibrillar A stimulates TNF secretion only from postnatal microglia Because proinflammatory cytokines such as TNF are associated with plaques in AD (McGeer and McGeer, 1995), and previous data have demonstrated that A fibrils stimulate microglial TNF secretion in vitro (Meda et al.”
Background
Diverse microglial responses after intrahippocampal administration of lipopolysaccharide
Herber, D. L., Maloney, J. L., Roth, L. M., Freeman, M. J., Morgan, D., & Gordon, M. N. (2005) · Glia · doi:10.1002/glia.20272 · Cited by 118
Apoptotic death of neurons exhibiting peripherin aggregates is mediated by the proinflammatory cytokine tumor necrosis factor-α
Robertson, J., Beaulieu, J., Doroudchi, M. M., Durham, H. D., Julien, J., & Mushynski, W. E. (2001) · The Journal of Cell Biology · doi:10.1083/jcb.200107058 · Cited by 116
“These results may be of relevance not only to ALS, but also to other neurodegenerative diseases such as Alzheimer’s and Parkinson’s disease, where the pathological role of protein aggregation in the disease mechanism remains elusive (Kawamata et al., 1992; McGeer and McGeer, 1995; Togo et al., 2001).”
BackgroundInfluential
Alzheimer's β-amyloid peptides induce inflammatory cascade in human vascular cells: the roles of cytokines and CD40
Suo, Z., Tan, J., Placzek, A., Crawford, F., Fang, C., & Mullan, M. (1998) · Brain Research · doi:10.1016/s0006-8993(98)00780-x · Cited by 116
Alzheimer disease and neuroinflammation
McGeer, P. L., McGeer, E. G., & Yasojima, K. (2000) · Springer eBooks · doi:10.1007/978-3-7091-6781-6_8 · Cited by 117
Self-citation
Cyclo-Oxygenase-2 Inhibitors
McGeer, P. L. (2000) · Drugs & Aging · doi:10.2165/00002512-200017010-00001 · Cited by 115
Self-citation
MicroRNA-455-3p as a Potential Biomarker for Alzheimer's Disease: An Update
Kumar, S., & Reddy, P. H. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00041 · Cited by 114
“…defects in cholinergic neurons; an age-dependent imbalance in hormones, and structural and functional changes in mitochondria (Terry et al., 1991; McGeer and McGeer, 1995; DeKosky et al., 1996; Nunomura et al., 2001; Reddy, 2006; Reddy and Beal, 2008; Du et al., 2010; Tampellini and Gouras,…”
Background
Blood-brain barrier dysfunction and Alzheimer’s disease: associations, pathogenic mechanisms, and therapeutic potential
Chen, Y., He, Y., Han, J., Wei, W., & Chen, F. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1258640 · Cited by 116
“An intense inflammatory reaction may produce autotoxicity in neurons, thus exacerbating the progression of AD and other nervous system diseases (McGeer and McGeer, 1995; Figure 3).”
Background
Nerve growth factor (NGF) expression in rat microglia is induced by adenosine A2a-receptors
Heese, K., Fiebich, B. L., Bauer, J., & Otten, U. (1997) · Neuroscience Letters · doi:10.1016/s0304-3940(97)00545-4 · Cited by 114
Fruit Polyphenols and Their Effects on Neuronal Signaling and Behavior in Senescence
Joseph, J. A., Shukitt‐Hale, B., & Lau, F. C. (2007) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1395.052 · Cited by 114
Associations of cortical astrogliosis with cognitive performance and dementia status
Kashon, M. L., Ross, G. W., O'Callaghan, J. P., Miller, D. B., Petrovitch, H., Burchfiel, C. M., Sharp, D. S., Markesbery, W. R., Davis, D. G., Hardman, J. M., et al. (2005) · Journal of Alzheimer s Disease · doi:10.3233/jad-2004-6604 · Cited by 115
“Astrogliosis has been documented in postmortem tissue from individuals with AD [8,33], prion diseases [58], and other neural diseases.”
Aging‐associated up‐regulation of neuronal 5‐lipoxygenase expression: putative role in neuronal vulnerability
Uz, T., Pesold, C., Longone, P., & Manev, H. (1998) · The FASEB Journal · doi:10.1096/fasebj.12.6.439 · Cited by 114
Sodium Salicylate and 17β‐Estradiol Attenuate Nuclear Transcription Factor NF‐κB Translocation in Cultured Rat Astroglial Cultures Following Exposure to Amyloid Aβ1‐40 and Lipoplysaccharides
Dodel, R. C., Du, Y., Bales, K. R., Gao, F., & Paul, S. M. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0731453.x · Cited by 114
Loss of perineuronal net N-acetylgalactosamine in Alzheimer’s disease
Baig, S., Wilcock, G. K., & Love, S. (2005) · Acta Neuropathologica · doi:10.1007/s00401-005-1060-2 · Cited by 112
“Microglial activation is a prominent feature of AD [1, 36, 47].”
Background
APOE*E2 allele delays age of onset in PSEN1 E280A Alzheimer’s disease
Vélez, J. I., Lopera, F., Sepulveda-Falla, D., Patel, H. R., Johar, A. S., Chuah, A., Tobón, C., Rivera, D., Villegas, A., Cai, Y., et al. (2016) · Molecular Psychiatry · doi:10.1038/mp.2015.177 · Cited by 111
Alzheimer's Disease, β-Amyloid Protein and Zinc
Huang, X., Cuajungco, M. P., Atwood, C., Moir, R. D., Tanzi, R. E., & Bush, A. I. (2000) · Journal of Nutrition · doi:10.1093/jn/130.5.1488s · Cited by 114
Alteration of transcription factors NF-κB and STAT1 in Alzheimer's disease brains
Kitamura, Y., Shimohama, S., Ota, T., Matsuoka, Y., Nomura, Y., & Taniguchi, T. (1997) · Neuroscience Letters · doi:10.1016/s0304-3940(97)00797-0 · Cited by 99
Helicobacter pylori and Alzheimer's disease: a possible link
Malaguarnera, M., Bella, R., Alagona, G., Ferri, R., Carnemolla, A., & Pennisi, G. (2004) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2004.05.008 · Cited by 112
“Chronic inflammatory processes seem to be present in the AD brain, as shown by the activated microglia and the immunereactive associated protein [25].”
Background
Interaction of Alzheimer β-amyloid peptide with the human monocytic cell line THP-1 results in a protein kinase C-dependent secretion of tumor necrosis factor-α
Klegeris, A., Walker, D. G., & McGeer, P. L. (1997) · Brain Research · doi:10.1016/s0006-8993(96)01229-2 · Cited by 110
Self-citation
Role of immunological factors in the pathophysiology and diagnosis of bipolar disorder: Comparison with schizophrenia
Altamura, A. C., Buoli, M., & Pozzoli, S. M. (2013) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.12089 · Cited by 113
Complement anaphylatoxin C5a neuroprotects through mitogen‐activated protein kinase‐dependent inhibition of caspase 3
Mukherjee, P., & Pasinetti, G. M. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00167.x · Cited by 111
Immune response gene expression increases in the aging murine hippocampus
Terao, A., Apte-Deshpande, A. D., Dousman, L., Morairty, S. R., Eynon, B. P., Kilduff, T. S., & Freund, Y. R. (2002) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(02)00317-x · Cited by 111
“Several lines of evidence suggest that neurodegeneration observed in AD is due in part to microglial activation and the induction of inflammatory response genes at sites of pathology (Akiyama, 1994; Kalehua et al., 2000; McGeer and McGeer, 1995; Rogers et al., 1988).”
Background
Role of the Immune System in the Pathogenesis, Prevention and Treatment of Alzheimer??s Disease
Blasko, I., & Grubeck-Loebenstein, B. (2003) · Drugs & Aging · doi:10.2165/00002512-200320020-00002 · Cited by 108
“[13,14] Following activation, microglial cells also produce acute-phase proteins, complement components, prostaglandins and cytokines.”
Background
Dissecting the signaling pathway of nicotine‐mediated neuroprotection in a mouse Alzheimer disease model
Liu, Q., Zhang, J., Zhu, H., Qin, C., Chen, Q., & Zhao, B. (2006) · The FASEB Journal · doi:10.1096/fj.06-5841com · Cited by 112
In vivo imaging of neuroinflammation
Cagnin, A. (2002) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(02)00107-4 · Cited by 110
Inflammatory markers in younger vs elderly normal volunteers and in patients with Alzheimer’s disease
Maes, M. H. J., Devos, N., Wauters, A., Demedts, P., Maurits, V., Neels, H. M., Bosmans, E., Altamura, C. A., Lin, A., Song, C., et al. (1999) · Journal of Psychiatric Research · doi:10.1016/s0022-3956(99)00016-3 · Cited by 110
Activation of Mu Opioid Receptors Inhibits Microglial Cell Chemotaxis
Chao, C. C., Hu, S., Shark, K. B., Sheng, W. S., Gekker, G., & Peterson, P. K. (1997) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)36668-6 · Cited by 110
The beneficial effects of berries on cognition, motor behaviour and neuronal function in ageing
Shukitt‐Hale, B., Bielinski, D. F., Lau, F. C., Willis, L., Carey, A. N., & Joseph, J. A. (2015) · British Journal Of Nutrition · doi:10.1017/s0007114515003451 · Cited by 110
Neuron-astrocyte cross-talk during synaptic transmission: physiological and neuropathological implications
Bezzi, P., Domercq, M., Vesce, S., & Volterra, A. (2001) · Progress in brain research · doi:10.1016/s0079-6123(01)32081-2 · Cited by 108
Different methylation of the TNF-alpha promoter in cortex and substantia nigra: Implications for selective neuronal vulnerability
Pieper, H. C., Evert, B. O., Kaut, O., Riederer, P. F., Waha, A., & Wüllner, U. (2008) · Neurobiology of Disease · doi:10.1016/j.nbd.2008.09.010 · Cited by 108
“Inflammation has long been noticed in the brains of patients with neurodegenerative disorders, including Parkinson's disease (PD) and Alzheimer's disease (AD) (McGeer & McGeer, 1995).”
Background
Effect of natural exogenous antioxidants on aging and on neurodegenerative diseases
Guerra‐Araiza, C., Álvarez-Mejía, L., Sánchez‐Torres, S., Farfán‐García, E. D., Mondragón‐Lozano, R., Pinto‐Almazán, R., & Salgado‐Ceballos, H. (2013) · Free Radical Research · doi:10.3109/10715762.2013.795649 · Cited by 110
Brain inflammatory response induced by intracerebroventricular infusion of lipopolysaccharide: an immunohistochemical study
Hauss‐Wegrzyniak, B., Lukovic, L., Bigaud, M., & Stoeckel, M. E. (1998) · Brain Research · doi:10.1016/s0006-8993(98)00227-3 · Cited by 108
Human Microglia Transplanted in Rat Focal Ischemia Brain Induce Neuroprotection and Behavioral Improvement
Narantuya, D., Nagai, A., Sheikh, A. M., Masuda, J., Kobayashi, S., Yamaguchi, S., & Kim, S. U. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011746 · Cited by 106
“Microglia are immunocompetent cells of central nervous system (CNS), which are activated in response to injury and diseases, and adopt a phagocytic and cytokine secreting phenotype [1–4].”
Background
Expression of mutant alpha-synuclein modulates microglial phenotype in vitro
Rojanathammanee, L., Murphy, E. J., & Combs, C. K. (2011) · Journal of Neuroinflammation · doi:10.1186/1742-2094-8-44 · Cited by 106
“A number of chronic neurodegenerative diseases, including Parkinson’s disease (PD), Alzheimer’s disease, and multiple sclerosis display an apparently aberrant microglial behavior that is hypothesized to contribute to disease progression [6-8].”
Background
Tyrosine hydroxylase (TH), its cofactor tetrahydrobiopterin (BH4), other catecholamine-related enzymes, and their human genes in relation to the drug and gene therapies of Parkinson’s disease (PD): historical overview and future prospects
Nagatsu, T., & Nagatsu, I. (2016) · Journal of Neural Transmission · doi:10.1007/s00702-016-1596-4 · Cited by 109
“Neuroinflammation in PD PD, Alzheimer’s disease, and other neurodegenerative diseases are accompanied by neuroinflammation by activated microglia (Hirsch et al. 2012; McGeer et al. 1988; McGeer and McGeer 1995; Nagatsu and Sawada 2005; Sawada et al. 2007; Tansey and Goldberg 2010).”
Background
Does aspirin protect against Alzheimer's dementia? A study in a Swedish population-based sample aged ?80�years
Nilsson, S. E., Johansson, B., Takkinen, S., Zarit, S., McClearn, G., Melander, A., & Berg, S. (2003) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-003-0618-y · Cited by 104
“Alzheimer’s disease may at least in part be secondary to inflammatory processes in cognitive brain centres, the microglia being of central importance [18].”
Background
Optical coherence tomography as retinal imaging biomarker of neuroinflammation/neurodegeneration in systemic disorders in adults and children
Vujosevic, S., Parra, M. M., Hartnett, M. E., O’Toole, L., Nuzzi, A., Limoli, C., Villani, E., & Nucci, P. (2022) · Eye · doi:10.1038/s41433-022-02056-9 · Cited by 109
Apoptosis of uninfected cells induced by HIV envelope glycoproteins
Ahr, B., Robert-Hebmann, V., Devaux, C. A., & Biard‐Piechaczyk, M. (2004) · Retrovirology · doi:10.1186/1742-4690-1-12 · Cited by 105
“In addition to indirect neuronal injury triggered by neurotoxic molecules released from HIV-infected or -activated macrophages and microglia [140-144], HIV Env directly triggers apoptosis of both primary rodent and human neurons [81,145-150] and astrocytes [151-153] and is probably a cause of CNS injury in AIDS [81,15…”
Background
Activation of microglia and chemokines in light-induced retinal degeneration.
Zhang, C., Shen, J. K., Lam, T. T., Zeng, H., Chiang, S. K. S., Yang, F. W., & Tso, M. O. M. (2005) · PubMed · Cited by 105
Increased susceptibility to metabolic dysregulation in a mouse model of Alzheimer's disease is associated with impaired hypothalamic insulin signaling and elevated BCAA levels
Ruiz, H. H., Chi, T., Shin, A. C., Lindtner, C., Hsieh, W., Ehrlich, M. E., Gandy, S., & Buettner, C. (2016) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2016.01.008 · Cited by 107
“Chronic and/or excessive ER stress also contributes to the activation of autophagy pathways [35] and inflammation pathways [36], and brain inflammation is implicated in both AD [37] and diabetes [38].”
Background
Effects of amyloid precursor protein derivatives andoxidative stress on basal forebrain cholinergic systems inALZHEIMERS disease
Mattson, M. P., & Pedersen, W. A. (1998) · International Journal of Developmental Neuroscience · doi:10.1016/s0736-5748(98)00082-3 · Cited by 108
Autoantibodies in Neurodegenerative Diseases: Antigen-Specific Frequencies and Intrathecal Analysis
Terryberry, J. W., Thor, G. T., & Peter, J. B. (1998) · Neurobiology of Aging · doi:10.1016/s0197-4580(98)00049-9 · Cited by 104
Cilostazol is anti‐inflammatory in BV2 microglial cells by inactivating nuclear factor‐kappaB and inhibiting mitogen‐activated protein kinases
Jung, W., Lee, D., Park, C., Choi, Y. H., Choi, I., Park, S., Seo, S., Lee, S., Yea, S. S., Ahn, S., et al. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00615.x · Cited by 104
“Inflammation in the brain caused by activated microglia is a prominent pathological feature associated with the neurodegeneration caused by several diseases, including PD, AD, MS and amyotrophic lateral sclerosis (McGeer and McGeer, 1995; McGeer et al., 2001; Liu and Hong, 2003).”
Background
Whole Brain Radiation-Induced Cognitive Impairment: Pathophysiological Mechanisms and Therapeutic Targets
Lee, Y. W., Cho, H. J., Lee, W. H., & Sonntag, W. E. (2012) · Biomolecules & Therapeutics · doi:10.4062/biomolther.2012.20.4.357 · Cited by 103
“Furthermore, treatment with antioxidant compounds or non-steroidal anti-infl ammatory drugs (NSAIDs) exhibited benefi cial effects such as delaying the onset or slowing the progression of neurodegenerative diseases including AD and PD (McGeer and McGeer, 1995; Akiyama et al., 2000).”
Background
Promising Metabolite Profiles in the Plasma and CSF of Early Clinical Parkinson's Disease
Stoessel, D., Schulte, C., dos Santos, M. C. T., Scheller, D., Rebollo‐Mesa, I., Deuschle, C., Walther, D., Schauer, N., Berg, D., da Costa, A. N., et al. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00051 · Cited by 107
“PAF is known for its contribution to inflammatory responses in the brain (Bazan, 2006) and elevated levels are associated with the central nervous system pathophysiology (McGeer and McGeer, 1995).”
Tauroursodeoxycholic acid reduces glial cell activation in an animal model of acute neuroinflammation
Yanguas-Casás, N., Barreda-Manso, M. A., Nieto-Sampedro, M., & Romero-Ramírez, L. (2014) · Journal of Neuroinflammation · doi:10.1186/1742-2094-11-50 · Cited by 103
“This chronic neuroinflammation causes the loss of white and grey matter that leads to functional deficits [6,7] that characterize the pathology of neurodegenerative diseases [8,9], stroke [10], and traumatic brain injuries [11].”
Background
Complement Association with Neurons and β-Amyloid Deposition in the Brains of Aged Individuals with Down Syndrome
Head, E., Azizeh, B. Y., Lott, I. T., Tenner, A. J., Cotman, C. W., & Cribbs, D. H. (2001) · Neurobiology of Disease · doi:10.1006/nbdi.2000.0380 · Cited by 103
Photobiomodulation by low-power laser irradiation attenuates Aβ-induced cell apoptosis through the Akt/GSK3β/β-catenin pathway
Liang, J., Liu, L., & Xing, D. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2012.08.003 · Cited by 102
Isoprostanes, Novel Markers of Oxidative Injury, Help Understanding the Pathogenesis of Neurodegenerative Diseases
Greco, A., Minghetti, L., & Levi, G. (2000) · Neurochemical Research · doi:10.1023/a:1007608615682 · Cited by 103
“The extensive astrocytosis and microglial activation observed in the cerebral cortex of CJD patients as well as in animal models of TSEs support the hypothesis that inflammation, driven by activated glial cells, may participate to the pathogenesis of CJD, as in other chronic neurodegenerative diseases ( 60 ,61).”
Background
Huperzine A and tacrine attenuate ?-amyloid peptide-induced oxidative injury
Xiao, X., Wang, R., & Tang, X. C. (2000) · Journal of Neuroscience Research · doi:10.1002/1097-4547(20000901)61:5 · Cited by 101
Mast Cell Tryptase Induces Microglia Activation via Protease-activated Receptor 2 Signaling
Zhang, S., Zeng, X., Yang, H., Hu, G., & He, S. (2012) · Cellular Physiology and Biochemistry · doi:10.1159/000171029 · Cited by 103
Longevity Pathways (mTOR, SIRT, Insulin/IGF-1) as Key Modulatory Targets on Aging and Neurodegeneration
Mazucanti, C. H., Cabral‐Costa, J. V., Vasconcelos, A. R., Andreotti, D. Z., Scavone, C., & Kawamoto, E. M. (2015) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026615666150610125715 · Cited by 103
“Aβ protein can induce free radical and reactive oxygen species (ROS) production, that can induce to neuroinflammation driven by increased microglia and astrocyte reactivity, which is likely to underpin many AD-associated abnormalities [11, 12].”
Background
Aspirin and other non-steroidal anti-inflammatory drugs for the prevention of dementia
Jordan, F., Quinn, T. J., McGuinness, B., Passmore, P., Kelly, J. P., Smith, C. T., Murphy, K., & Devane, D. (2020) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011459.pub2 · Cited by 102
Increased Brain Synthesis of Prostaglandin E2and F2-Isoprostane in Human and Experimental Transmissible Spongiform Encephalopathies
Minghetti, L., Greco, A., Cardone, F., Puopolo, M., Ladogana, A., Almonti, S., Cunningham, C. M., Perry, V. H., Pocchiari, M., & Levi, G. (2000) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/59.10.866 · Cited by 101
“kinson disease (5, 6), but limited information is, to date,”
Background
Transgenic mouse models of Alzheimer’s disease
Janus, C., Chishti, M. A., & Westaway, D. (2000) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/s0925-4439(00)00033-8 · Cited by 101
Nucleotide receptors in the nervous system
Barnard, E. A., Simon, J., & Webb, T. E. (1997) · Molecular Neurobiology · doi:10.1007/bf02740631 · Cited by 101
Differential distribution of cAMP‐specific phosphodiesterase 7A mRNA in rat brain and peripheral organs
Miró, X., Pérez-Torres, S., Palacios, J. M., Puigdomènech, P., & Mengod, G. (2001) · Synapse · doi:10.1002/syn.1043 · Cited by 100
Nutritional intervention in brain aging: reducing the effects of inflammation and oxidative stress.
Lau, F. C., Shukitt‐Hale, B., & Joseph, J. A. (2007) · PubMed · Cited by 100
Cytokine expression and microglial activation in progressive supranuclear palsy
Fernández-Botrán, R., Ahmed, Z., Crespo, F. A., Gatenbee, C., Gonzalez, J., Dickson, D. W., & Litvan, I. (2011) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2011.06.007 · Cited by 93
LPS-induced neuroinflammatory effects do not recover with time
Hauss‐Wegrzyniak, B., Vraniak, P., & Wenk, G. L. (2000) · Neuroreport · doi:10.1097/00001756-200006050-00032 · Cited by 99
Lipid Signaling and Synaptic Plasticity
Sang, N., & Chen, C. (2006) · The Neuroscientist · doi:10.1177/1073858406290794 · Cited by 98
“…implicated in synaptic signaling, and in traumatic brain injury, stroke, and certain neurologic disorders such as epilepsy and Alzheimer’s disease (McGeer and McGeer 1995; Miettinen and others 1997; Nakayama and others 1998; Ho and others 1999; Hewett and others 2000; Iadecola and others 2001;…”
Background
Chemically induced neuronal damage and gliosis: enhanced expression of the proinflammatory chemokine, monocyte chemoattractant protein (MCP)-1, without a corresponding increase in proinflammatory cytokines
Little, A. R., Benkovic, S. A., Miller, D. B., & O'Callaghan, J. P. (2002) · Neuroscience · doi:10.1016/s0306-4522(02)00359-7 · Cited by 99
Increase in the density of resting microglia precedes neuritic plaque formation and microglial activation in a transgenic model of Alzheimer's disease
Rodríguez, J. J., Witton, J., Olabarria, M., Noristani, H. N., & Verkhratsky, A. (2010) · Cell Death & Disease · doi:10.1038/cddis.2009.2 · Cited by 114
“Discussion Although it has long been known that activated microglia are associated with compact A β plaques”
Background
Alzheimer’s disease (AD) therapeutics – 1: Repeated clinical failures continue to question the amyloid hypothesis of AD and the current understanding of AD causality
Mullane, K., & Williams, M. (2018) · Biochemical Pharmacology · doi:10.1016/j.bcp.2018.09.026 · Cited by 98
Human misfolded truncated tau protein promotes activation of microglia and leukocyte infiltration in the transgenic rat model of tauopathy
Žilka, N., Stožická, Z., Kováč, A., Pilipcinec, E., Bugos, O., & Novák, M. (2009) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2009.01.013 · Cited by 101

Authors: MCGEER, P., & MCGEER, E.
Affiliations: University of British Columbia (CA)
Corresponding author: MCGEER, P
Venue: Brain Research Reviews
Publisher: Elsevier BV
Published: 1995-09
Volume: 21
Issue: 2
Pages: 195-218
ISSN: 0165-0173 (ISSN-L)
DOI: 10.1016/0165-0173(95)00011-9
OpenAlex: W2090930997
Cited by: 1,287
References: 319
Citations by year: 2026: 5 · 2025: 12 · 2024: 17 · 2023: 14 · 2022: 24 · 2021: 19 · 2020: 16 · 2019: 18 · 2018: 27 · 2017: 29 · 2016: 19 · 2015: 29 · 2014: 46 · 2013: 42 · 2012: 36
FWCI: 5.59
Type: journal article
Language: en
Open access: closed
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: Brain Research Reviews (publishedVersion)
PubMed (publishedVersion)
Funders: Alzheimer Society of B.C.
Topics: Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
Keywords: neuroinflammation, Alzheimer's disease, neurodegenerative diseases, microglia, astrocytes, complement system, inflammatory cytokines, acute phase proteins, chronic inflammation, anti-inflammatory therapy, indomethacin, anti-inflammatory agents, neuroprotection
MeSH terms: Alzheimer Disease, Brain, Humans, Inflammation, Nerve Degeneration, Nervous System Diseases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

The inflammatory response system of brain: implications for therapy of Alzheimer and other neurodegenerative diseases

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks